https://www.targetedonc.com/view/maximal-tumor-debulking-with-systemic-therapy-does-not-impact-qol-in-mcrc
While a notable difference in the occurrence of adverse events was seen between patients treated with maximal tumor debulking and standard systemic therapy vs systemic therapy alone, health-related quality-of-life and fatigue scales showed no substantial diff…
Create an account or login to join the discussion